Stay updated on Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study record for the TAK-981 head and neck cancer trial is displayed, including its design, participant criteria, locations, interventions, and outcome measures.
    Difference
    54%
    Check dated 2026-11-08T04:43:07.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The study record page displays a 403 Forbidden message with a Home link. The site revision changed from v3.7.2 to v3.8.0.
    Difference
    0.6%
    Check dated 2026-11-01T01:54:09.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and says some content may use “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T01:53:36.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.3%
    Check dated 2026-10-18T01:39:32.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision updated from v3.7.0 to v3.7.1 while the page continued to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T02:05:08.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, and the expected study content has been removed from view. The header and footer remain, but the core NCT04065555 study details and related navigation are no longer accessible on this page.
    Difference
    19%
    Check dated 2026-09-20T01:05:09.000Z thumbnail image

Stay in the know with updates to Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial page.